BR0313611A - Uso da combinação de ciclesonida e anti-histaminas para o tratamento de rinite alérgica - Google Patents

Uso da combinação de ciclesonida e anti-histaminas para o tratamento de rinite alérgica

Info

Publication number
BR0313611A
BR0313611A BR0313611-6A BR0313611A BR0313611A BR 0313611 A BR0313611 A BR 0313611A BR 0313611 A BR0313611 A BR 0313611A BR 0313611 A BR0313611 A BR 0313611A
Authority
BR
Brazil
Prior art keywords
ciclesonide
treatment
allergic rhinitis
combination
antihistamine
Prior art date
Application number
BR0313611-6A
Other languages
English (en)
Inventor
Degenhard Marx
Helgert M Ller
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BR0313611A publication Critical patent/BR0313611A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"USO DA COMBINAçãO DE CICLESONIDA E ANTI-HISTAMINAS PARA O TRATAMENTO DE RINITE ALéRGICA". A presente invenção refere-se a uma combinação de ciclesonida com anti-histaminas.
BR0313611-6A 2002-08-30 2003-08-29 Uso da combinação de ciclesonida e anti-histaminas para o tratamento de rinite alérgica BR0313611A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02019406 2002-08-30
PCT/EP2003/009622 WO2004019955A1 (en) 2002-08-30 2003-08-29 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

Publications (1)

Publication Number Publication Date
BR0313611A true BR0313611A (pt) 2005-06-21

Family

ID=31970274

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0313611-6A BRPI0313611B1 (pt) 2002-08-30 2003-08-29 Composição farmacêutica para o tratamento de rinite alérgica e/ou conjuntivite alérgica para aplicação na mucosa e uso de dita composição
BR0313611-6A BR0313611A (pt) 2002-08-30 2003-08-29 Uso da combinação de ciclesonida e anti-histaminas para o tratamento de rinite alérgica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0313611-6A BRPI0313611B1 (pt) 2002-08-30 2003-08-29 Composição farmacêutica para o tratamento de rinite alérgica e/ou conjuntivite alérgica para aplicação na mucosa e uso de dita composição

Country Status (21)

Country Link
US (2) US7879832B2 (pt)
EP (2) EP2295062B1 (pt)
JP (2) JP4746318B2 (pt)
KR (1) KR101067795B1 (pt)
CN (1) CN1674916A (pt)
AT (1) ATE472329T1 (pt)
AU (1) AU2003273396B2 (pt)
BR (2) BRPI0313611B1 (pt)
CA (1) CA2495830C (pt)
DE (1) DE60333205D1 (pt)
DK (1) DK1545548T3 (pt)
ES (2) ES2393864T3 (pt)
IL (1) IL166483A (pt)
MX (1) MXPA05001885A (pt)
NO (1) NO335400B1 (pt)
NZ (1) NZ538954A (pt)
PL (1) PL373433A1 (pt)
PT (1) PT1545548E (pt)
SI (1) SI1545548T1 (pt)
WO (1) WO2004019955A1 (pt)
ZA (1) ZA200500719B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
DE60323138D1 (de) * 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
JP2006527237A (ja) * 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
EP2486942B1 (en) 2004-11-24 2018-10-10 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006097458A1 (en) * 2005-03-15 2006-09-21 Nycomed Gmbh Novel combination
US20080015241A1 (en) * 2006-07-13 2008-01-17 Cornerstone Biopharma, Inc. All day rhinitic condition treatment regimen
US20080311196A1 (en) * 2006-07-13 2008-12-18 White Donna F All Day Rhinitic Condition Treatment Regimen
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
KR100878698B1 (ko) * 2007-04-05 2009-01-13 한미약품 주식회사 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물
HUE026106T2 (en) * 2010-10-06 2016-05-30 Bausch & Lomb Bepotastine preparations
BR112013017183A2 (pt) * 2011-01-04 2017-07-25 Bausch & Lomb composições de bepostatina
BR112015023328A2 (pt) 2013-03-13 2017-07-18 Flatley Discovery Lab compostos de piridazinona e métodos para o tratamento de fibrose cística
CN106692115A (zh) * 2015-11-13 2017-05-24 天津金耀集团有限公司 一种环索奈德混悬鼻喷剂组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (pt) * 1963-04-24
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
DE3877904D1 (de) * 1987-11-13 1993-03-11 Asta Pharma Ag Azelastin enthaltende arzneimittel zur anwendung in der nase und/oder am auge.
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
HU220868B1 (en) * 1993-04-02 2002-06-29 Byk Gulden Lomberg Chem Fab New prednisolone derivative, process for its production, use of the same and pharmaceutical composition containing the same
EP0709099A3 (en) 1994-09-28 1996-07-24 Senju Pharma Co Aqueous suspension for nasal administration containing cyclodextrin
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
WO1997001341A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
AU6392496A (en) 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
EP0954318A1 (en) 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
FR2754712B1 (fr) * 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US20020111495A1 (en) * 1997-04-04 2002-08-15 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
CN1253508A (zh) 1997-04-30 2000-05-17 沃尼尔－朗伯公司 局部鼻用抗炎组合物
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6297227B1 (en) * 1998-09-10 2001-10-02 Schering Corporation Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
AU772406B2 (en) 1999-11-18 2004-04-29 Alcon Inc. Use of H1 antagonist and a safe steroid to treat eye conditions
US6653313B2 (en) 2000-08-10 2003-11-25 Warner-Lambert Company Llc 1,4-dihydropyridine compounds as bradykinin antagonists
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
BR0214643A (pt) 2001-12-05 2004-11-03 Alcon Inc Aplicação de um antagonista h1, e um esteróide seguro para tratar rinite
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
JP2006508138A (ja) * 2002-11-12 2006-03-09 アルコン，インコーポレイテッド アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用

Also Published As

Publication number Publication date
MXPA05001885A (es) 2005-06-03
ATE472329T1 (de) 2010-07-15
CA2495830A1 (en) 2004-03-11
KR20050058400A (ko) 2005-06-16
IL166483A (en) 2013-11-28
EP2295062A1 (en) 2011-03-16
DK1545548T3 (da) 2010-09-27
EP1545548A1 (en) 2005-06-29
JP2011021043A (ja) 2011-02-03
CA2495830C (en) 2012-08-21
CN1674916A (zh) 2005-09-28
US20050245493A1 (en) 2005-11-03
SI1545548T1 (sl) 2010-11-30
IL166483A0 (en) 2006-01-15
BRPI0313611B1 (pt) 2018-03-06
US8486923B2 (en) 2013-07-16
KR101067795B1 (ko) 2011-09-27
AU2003273396B2 (en) 2008-12-11
ZA200500719B (en) 2006-02-22
US7879832B2 (en) 2011-02-01
NO20051521L (no) 2005-03-22
ES2393864T3 (es) 2012-12-28
JP4746318B2 (ja) 2011-08-10
DE60333205D1 (de) 2010-08-12
NZ538954A (en) 2007-04-27
EP2295062B1 (en) 2012-08-29
NO20051521D0 (no) 2005-03-22
AU2003273396A1 (en) 2004-03-19
US20110092471A1 (en) 2011-04-21
EP1545548B1 (en) 2010-06-30
JP2005539044A (ja) 2005-12-22
PL373433A1 (en) 2005-08-22
PT1545548E (pt) 2010-09-02
NO335400B1 (no) 2014-12-08
ES2348034T3 (es) 2010-11-29
WO2004019955A1 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
NO20051521D0 (no) Anvendelse av kombinasjonen av ciclesonid og antihistaminer for behandlingen av allergisk rhinitt
DE60229922D1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
NL300936I2 (nl) Semaglutide
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
CY1105080T1 (el) Ενωσεις θειενοπυρρολυλιου και φουρανοπυρρολυλιου και η χρηση τους ως συνδετες η4 υποδοχεα ισταμινης
CY2013043I1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
CY1104983T1 (el) Αντινεοπλασματικοι συνδυασμοι
NO20044054L (no) Administrering av midler for behandling av betennelse
PT1392292E (pt) Piranoindazoles e sua utilizacao para o tratamento de glaucoma
BRPI0607304A2 (pt) compostos tendo atividade analgésica e/ou imunoestimulante
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
DK1478629T3 (da) N-aryl-2-oxazolidinon-5-carboxamider og deres derivater og deres anvendelse som antibakterielle midler
PT1411926E (pt) Inibidores de integrina para o tratamento de doencas oftalmicas
SE9904377D0 (sv) Pharmaceutical combinations
ATE406159T1 (de) Behandlung von hyperlipidämie
CY1116137T1 (el) Χρηση των αναστολεων il-18 σε διαταραχες υπερευαισθησιας
ITVR20010031A0 (it) Uso di epigallocatechin-3-gallato o suoi derivati nella profilassi e nel trattamento delle malattie neurodegenerative.
BRPI0507157A (pt) uso de fator viia ou de um equivalente de fator viia, kit de partes para tratamento de trauma, e, métodos para tratar trauma e para prevenir, tratar trauma
DE60200302D1 (de) Laseraugenbehandlungseinrichtung
ATE328608T1 (de) Verfahren und zusammensetzungen mit kombinationen aus terfenadinmetaboliten und leukotrienhemmer
NO20053247L (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
BRPI0408322A (pt) uso de um fibrato e orlistat para o tratamento da obesidade
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
BRPI0409586A (pt) ácidos hidroxámicos úteis no tratamento de distúrbios hiperproliferativos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B25A Requested transfer of rights approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24D Patent annual fee: restoration after fee payment